MENU
+Compare
NEGXF
Stock ticker: OTC
AS OF
Apr 7 closing price
Price
$0.20
Change
+$0.01 (+5.26%)
Capitalization
16.64M

NEGXF stock forecast, quote, news & analysis

NexgenRx Inc administers, adjudicates, and pays drug, dental and other extended health-care claims for the beneficiaries of health benefit plans underwritten by its customers using proprietary computer software and provides ancillary services... Show more

NEGXF
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for NEGXF with price predictions
Feb 03, 2026

Aroon Indicator for NEGXF shows an upward move is likely

NEGXF's Aroon Indicator triggered a bullish signal on January 21, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 50 similar instances where the Aroon Indicator showed a similar pattern. In of the 50 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 22 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for NEGXF turned negative on January 06, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 13 similar instances when the indicator turned negative. In of the 13 cases the stock turned lower in the days that followed. This puts the odds of success at .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.102) is normal, around the industry mean (19.502). P/E Ratio (23.933) is within average values for comparable stocks, (99.648). NEGXF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.997). Dividend Yield (0.026) settles around the average of (0.030) among similar stocks. P/S Ratio (1.660) is also within normal values, averaging (64.610).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. NEGXF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NEGXF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 97, placing this stock better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Teladoc Health (NYSE:TDOC).

Industry description

This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.

Market Cap

The average market capitalization across the Services to the Health Industry Industry is 1.51B. The market cap for tickers in the group ranges from 708 to 31.36B. VEEV holds the highest valuation in this group at 31.36B. The lowest valued company is OTRKQ at 708.

High and low price notable news

The average weekly price growth across all stocks in the Services to the Health Industry Industry was -5%. For the same Industry, the average monthly price growth was -9%, and the average quarterly price growth was -8%. OHCFF experienced the highest price growth at 20%, while RMHI experienced the biggest fall at -43%.

Volume

The average weekly volume growth across all stocks in the Services to the Health Industry Industry was 28%. For the same stocks of the Industry, the average monthly volume growth was 61% and the average quarterly volume growth was 4%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 54
P/E Growth Rating: 73
Price Growth Rating: 66
SMR Rating: 84
Profit Risk Rating: 97
Seasonality Score: -34 (-100 ... +100)
View a ticker or compare two or three
NEGXF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry ServicestotheHealthIndustry

Profile
Fundamentals
Details
Industry
N/A
Address
191 The West Mall
Phone
+1 416 695-3393
Employees
20
Web
http://www.nexgenrx.com